Get the Stockscreener App
6.46
0.94%
0.06
Pre-market:
6.46
Inogen Inc stock is traded at $6.46, with a volume of 172.93K.
It is up +0.94% in the last 24 hours and up +1.25% over the past month.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
See More
Previous Close:
$6.40
Open:
$6.45
24h Volume:
172.93K
Relative Volume:
0.54
Market Cap:
$174.90M
Revenue:
$348.67M
Net Income/Loss:
$-22.75M
P/E Ratio:
-7.537
EPS:
-0.8571
Net Cash Flow:
$-21.60M
1W Performance:
+6.60%
1M Performance:
+1.25%
6M Performance:
-5.42%
1Y Performance:
+3.36%
1-Day Range:
$6.42
$6.515
1-Week Range:
$6.12
$6.65
52-Week Range:
$5.3401
$9.13
Inogen Inc Stock (INGN) Company Profile
Name
Inogen Inc
Sector
Industry
Phone
805-562-0500
Address
500 CUMMINGS CENTER, BEVERLY, CA
Compare INGN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
6.46 | 174.90M | 348.67M | -22.75M | -21.60M | -0.8571 |
ABT
Abbott Laboratories
|
88.67 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.94 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.38 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
46.76 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.28 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-16-25 | Initiated | B. Riley Securities | Buy |
| May-22-25 | Upgrade | Needham | Hold → Buy |
| Feb-15-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Aug-08-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-14-23 | Downgrade | Needham | Buy → Hold |
| Jan-17-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-09-21 | Upgrade | Needham | Hold → Buy |
| Nov-02-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Aug-05-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-04-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-14-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-20 | Downgrade | Needham | Buy → Hold |
| May-06-20 | Reiterated | Needham | Buy |
| Nov-06-19 | Upgrade | Needham | Hold → Buy |
| Sep-13-19 | Reiterated | Piper Jaffray | Overweight |
| Aug-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Aug-08-19 | Downgrade | Stifel | Buy → Hold |
| Aug-07-19 | Downgrade | Needham | Buy → Hold |
| Jun-28-19 | Downgrade | Needham | Strong Buy → Buy |
| May-08-19 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-19 | Reiterated | Needham | Strong Buy |
| Feb-27-19 | Reiterated | Needham | Strong Buy |
| Nov-20-18 | Upgrade | Needham | Buy → Strong Buy |
| Nov-07-18 | Reiterated | Needham | Buy |
| Sep-10-18 | Downgrade | Needham | Strong Buy → Buy |
| Aug-22-18 | Resumed | Stifel | Buy |
| Aug-08-18 | Reiterated | Needham | Strong Buy |
| Jun-06-18 | Initiated | KeyBanc Capital Mkts | Sector Weight |
| May-01-18 | Reiterated | Needham | Strong Buy |
| Feb-28-18 | Reiterated | Needham | Strong Buy |
View All
Inogen Inc Stock (INGN) Latest News
Inogen Inc Stock (US45780L1044): Valuation metrics under the microscope - AD HOC NEWS
INGN SEC FilingsInogen Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Here's why you should retain Inogen stock in your portfolio for now - MSN
Former ZimVie CEO Joins Inogen’s Board of Directors - Medical Product Outsourcing
Inogen, Inc. Amended and Restated 2023 Equity Incentive Plan and Stock Option Agreement Details 57 - Minichart
Inogen Shareholders Approve Expanded Equity Incentive Plan - TipRanks
Inogen (NASDAQ: INGN) holders back equity plan but keep staggered board - Stock Titan
Inogen (INGN) director awarded 28,081 RSUs, boosting share holdings - Stock Titan
Inogen (INGN) director Jamali Vafa receives 28,081-share RSU grant - Stock Titan
Inogen Inc (INGN) awards director Glenn Boehnlein 28,081 stock units - Stock Titan
Inogen (NASDAQ: INGN) director granted 28,081 restricted stock units in equity award - Stock Titan
Inogen (NASDAQ: INGN) director awarded 28,081 restricted stock units - Stock Titan
Inogen (INGN) director receives 28,081-share restricted stock unit grant - Stock Titan
Jamali Vafa (INGN) files Form 3 disclosing 15,000 Inogen common shares - Stock Titan
· Analyst Forecast - MLQ.ai
Inogen (INGN) Advances as Trading Activity Picks Up, Testing ResistanceHot Stock Picks - newsline.com
Inogen Inc stock (US45780L1044): Nasdaq-listed oxygen therapy specialist sees active trading ahead o - AD HOC NEWS
Pulmonary Devices Market Competitive Analysis to 2031 | Inogen Inc., Invacare Corporation, O2 Concepts etc. - openPR.com
Inogen appoints Vafa Jamali to board of directors - Investing.com
Inogen Welcomes Three New Executive Team Members - Medical Product Outsourcing
Freedom Broker initiates Inogen stock coverage with buy rating on respiratory platform growth - Investing.com
INGN Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesAnalyst Earnings Estimate - newsline.com
Inogen Inc EVP Jennifer Yi Boyer sells $70,313 of common stock - Investing.com Canada
Inogen Inc EVP Jennifer Yi Boyer sells $70,313 of common stock By Investing.com - Investing.com South Africa
Inogen (INGN) HR chief sells 10,770 shares under Rule 10b5-1 plan - Stock Titan
Inogen Inc stock (US45780L1044): shares ease after May volatility as investors await next catalysts - AD HOC NEWS
[144] Inogen Inc SEC Filing - Stock Titan
INGN Q1 2026 Earnings: EPS Misses Estimates as Losses Widen, Stock DeclinesEarnings Surprise Report - The Legal Advocate
Inogen Inc (INGN) Holds Near Support as Shares Drift LowerInsider Selling Alerts - newsline.com
Inogen (INGN) Sees Mild Uptick, Consolidates Near Key ResistanceEarnings Breakout Stocks - newsline.com
Inogen Inc Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesEarnings Surprise Stocks - newsline.com
Q3 2025 Inogen Inc Earnings Call Transcript - GuruFocus
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now - Yahoo Finance
Inogen Earnings Call: International Strength Amid U.S. Strain - TipRanks
What Inogen (INGN)'s -1.25% Decline Means for Investors 2026-05-18Wave Equality - The Legal Advocate
Inogen stock (US45780L1044): respiratory player in focus after Q1 2026 update and restructuring plan - AD HOC NEWS
Inogen, IncCommon Stock (NQ: INGN - The Chronicle-Journal
Inogen (INGN) Q1 2026 Results Miss Estimates — EPS $-0.30 vs $-0.29Earnings Decline Risk - The Legal Advocate
Number of shareholders of Inogen, Inc. – FWB:6IO - TradingView
Inogen Q1 2026 slides: revenue beats amid profitability pressure By Investing.com - Investing.com Nigeria
Inogen Q1 2026 slides: revenue beats amid profitability pressure - Investing.com
Earnings call transcript: Inogen’s mixed Q1 2026 results with revenue beat - Investing.com Nigeria
Needham Upgrades Inogen (INGN) - MSN
How The Inogen (INGN) Story Is Shifting With New Targets And Execution Questions - Yahoo Finance
Inogen, Inc. (NASDAQ:INGN) Q1 2026 Earnings Call Transcript - Insider Monkey
Inogen (INGN) TTM Loss Narrows To US$22.7 Million Testing Bearish Profitability Narratives - Sahm
Inogen Inc. Earnings Call Highlights Transition Phase - TipRanks
Inogen (NASDAQ: INGN) Q1 2026 revenue rises 3% as net loss widens - Stock Titan
Inogen Inc stock (US45780L1044): Q1 revenue growth and valuation debate - AD HOC NEWS
INGN Stock Dips on Q1 Earnings Miss, Sales Up Y/Y, Gross Margin Improves - sharewise.com
Q1 2026 Inogen Inc Earnings Call Transcript - GuruFocus
Inogen Inc Stock (INGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):